Literature DB >> 24045555

Performance and reproducibility of gynecologic cytology interpretation using the FocalPoint system: results of the RODEO Study Team.

Maíra Degiovani Stein1, José Humberto T G Fregnani, Cristovam Scapulatempo, Allini Mafra, Natália Campacci, Adhemar Longatto-Filho.   

Abstract

OBJECTIVES: To assess whether automated screening in the cytologic examination of Papanicolaou smear slides results in smaller margins of error than manual screening.
METHODS: We compared cytotechnologists' performance and reproducibility of manual and automated screening of 10,165 consecutive cervical cytology slides examined at Barretos Cancer Hospital using the FocalPoint system.
RESULTS: In total, 83% of atypical squamous cells of undetermined significance and greater were classified as quintiles 1 and 2; no high-grade squamous intraepithelial lesions and greater were observed in quintile 5. No statistically significant differences were found between manual and automated screening, using cervical biopsy specimens as the gold standard.
CONCLUSIONS: FocalPoint safely screened high-grade lesions, which can be valuable for high-workload routines.

Entities:  

Keywords:  Automation; FocalPoint; Pap test; Quality control; SurePath

Mesh:

Year:  2013        PMID: 24045555     DOI: 10.1309/AJCPWL36JXMRESFH

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Cervicovaginal cytology in patients undergoing pelvic radiotherapy using the Focalpoint system: results from the RODEO study.

Authors:  Maíra Degiovani Stein; José Humberto T G Fregnani; Cristovam Scapulatempo-Neto; Adhemar Longatto-Filho
Journal:  Diagn Pathol       Date:  2015-01-16       Impact factor: 2.644

2.  Pelvic radiotherapy for cervical cancer affects importantly the reproducibility of cytological alterations evaluation.

Authors:  Fernanda A Lucena; Ricardo F A Costa; Maira D Stein; Carlos E M C Andrade; Geórgia F Cintra; Marcelo A Vieira; Rozany M Dufloth; José Humberto T G Fregnani; Ricardo Dos Reis
Journal:  BMC Clin Pathol       Date:  2018-10-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.